Insider · CIK 0001816160

Kihara James

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001816160

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-26	ACADACADIA PHARMACEUTICALS INCS Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−11.4K sh	$26.08	−$298K	13,088
2026-05-26	ACADACADIA PHARMACEUTICALS INCS Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−5,401 sh	$21.18	−$114K	24,509
2026-05-04	ACADACADIA PHARMACEUTICALS INCS Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−1,332 sh	$21.79	−$29K	29,129
2026-05-01	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	+2,596 sh	—	—	30,461
2026-05-01	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	−2,596 sh	—	—	2,596
2026-04-07	ACADACADIA PHARMACEUTICALS INCS Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−1,030 sh	$22.20	−$22.9K	27,865
2026-04-05	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	+2,010 sh	—	—	28,895
2026-04-05	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	−2,010 sh	—	—	0
2026-03-26	ACADACADIA PHARMACEUTICALS INCS Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−1,097 sh	$21.65	−$23.8K	26,897
2026-03-26	ACADACADIA PHARMACEUTICALS INCS Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−12 sh	$21.73	−$260.704	26,885
2026-03-25	ACADACADIA PHARMACEUTICALS INCS Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−833 sh	$21.47	−$17.9K	25,852
2026-03-25	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	+2,142 sh	—	—	27,994
2026-03-25	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	−2,142 sh	—	—	4,284
2026-03-24	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	+1,627 sh	—	—	26,685
2026-03-24	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	−1,627 sh	—	—	4,883
2026-03-06	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	PRINCIPAL ACCOUNTING OFFICER	AAward	+21.8K sh	—	—	21,766
2026-03-06	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	PRINCIPAL ACCOUNTING OFFICER	AAward	+6,332 sh	—	—	6,332
2025-11-18	ACADACADIA PHARMACEUTICALS INCS Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−4,084 sh	$23.69	−$96.8K	25,058
2025-11-17	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	+3,966 sh	—	—	25,176
2025-11-17	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	+3,966 sh	—	—	29,142
2025-11-17	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	−3,966 sh	—	—	0
2025-11-17	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	−3,966 sh	—	—	0
2025-05-16	ACADACADIA PHARMACEUTICALS INCS Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−2,000 sh	$25.00	−$50K	22,395
2025-05-16	ACADACADIA PHARMACEUTICALS INCS Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−2,000 sh	$20.00	−$40K	20,395
2025-05-02	ACADACADIA PHARMACEUTICALS INCS Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−1,327 sh	$14.60	−$19.4K	23,526
2025-05-01	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	+2,596 sh	—	—	24,853
2025-05-01	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	−2,596 sh	—	—	5,192
2025-04-08	ACADACADIA PHARMACEUTICALS INCS Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−1,028 sh	$14.82	−$15.2K	22,257
2025-04-05	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	+2,010 sh	—	—	23,285
2025-04-05	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	−2,010 sh	—	—	2,010
2025-03-26	ACADACADIA PHARMACEUTICALS INCS Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−1,095 sh	$17.05	−$18.7K	21,275
2025-03-25	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	+2,142 sh	—	—	22,370
2025-03-25	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	−2,142 sh	—	—	6,426
2025-03-24	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	PRINCIPAL ACCOUNTING OFFICER	AAward	+22.2K sh	—	—	22,152
2025-03-24	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	PRINCIPAL ACCOUNTING OFFICER	AAward	+6,510 sh	—	—	6,510
2025-02-24	ACADACADIA PHARMACEUTICALS INCS Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−475 sh	$19.96	−$9,481	20,228
2025-02-23	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	+840 sh	—	—	20,703
2025-02-23	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	−840 sh	—	—	0
2024-11-19	ACADACADIA PHARMACEUTICALS INCS Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−4,073 sh	$16.81	−$68.5K	19,863
2024-11-17	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	+3,965 sh	—	—	19,971
2024-11-17	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	+3,965 sh	—	—	23,936
2024-11-17	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	−3,965 sh	—	—	3,966
2024-11-17	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	−3,965 sh	—	—	3,966
2024-05-02	ACADACADIA PHARMACEUTICALS INCS Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−1,326 sh	$16.94	−$22.5K	14,370
2024-05-01	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	+2,596 sh	—	—	15,696
2024-05-01	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	−2,596 sh	—	—	7,788
2024-04-08	ACADACADIA PHARMACEUTICALS INCS Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−1,028 sh	$17.87	−$18.4K	13,862
2024-04-08	ACADACADIA PHARMACEUTICALS INCS Sale	PRINCIPAL ACCOUNTING OFFICER	SSale	−762 sh	$17.87	−$13.6K	13,100
2024-04-07	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	+1,489 sh	—	—	14,890
2024-04-07	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	PRINCIPAL ACCOUNTING OFFICER	MExercise/Conversion	−1,489 sh	—	—	0

Recent filings

Accepted (ET)
Jun 294
Kihara James0001816160-26-000009
SEC(opens sec.gov)
May 274
Kihara James0001816160-26-000008
SEC(opens sec.gov)
May 54
Kihara James0001816160-26-000007
SEC(opens sec.gov)
Apr 74
Kihara James0001816160-26-000005
SEC(opens sec.gov)
Mar 264
Kihara James0001816160-26-000003
SEC(opens sec.gov)
Mar 104
Kihara James0001816160-26-000002
SEC(opens sec.gov)
Nov 194
Kihara James0001816160-25-000004
SEC(opens sec.gov)

Companies

ACADIA PHARMACEUTICALS INCPRINCIPAL ACCOUNTING OFFICERACAD

Address

C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400

SAN DIEGO, CA, 92130